PSMA-targeted docetaxel (BIND-014) - Pfizer
BIND Therapeutics: JMP Securities Healthcare Conference (BIND Therapeutics) - Jul 11, 2014 - "BIND-14 Phase 2 NSCLC Interim KRAS Mutant Analysis"; "Data as of 5/9" 
P2 data • Non Small Cell Lung Cancer • Oncology
http://wsw.com/webcast/jmp24/BIND/
 
Jul 11, 2014
 
.
 
5831bf0a-d0ca-4be5-a3f6-5d959ddedd99.jpg